Ex vivo-model design and evaluation of the sensitivity of blast cells to chemotherapy as a way to personalize the treatment of acute myeloid leukemia
Despite continuous attempts to improve therapy, the outcomes of acute myeloid leukemia remain almost unchanged over last decades. Drugs made with a more complete understanding of the biology of acute myeloid leukemia do not equal the hopes for better prognosis. The best results are achieved only wit...
Saved in:
| Main Authors: | A. S. Polyakov, Ya. A. Noskov, Yu. V. Nikitin, V. V. Tyrenko, S. N. Kolubaeva, A. N. Bogdanov, V. N. Semelev, O. R. Petrova, S. V. Bondarchuk, D. K. Zhogolev, A. D. Zolotarev, A. V. Kovalev, Yu. E. Puchkova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2019-07-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/349 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COVID-19 in patients with acute leukemia: 3 years' experience of pandemic
by: T. S. Chudnova, et al.
Published: (2024-01-01) -
Treatment of acute myeloid leukemia in children
by: A. V. Popa, et al.
Published: (2022-11-01) -
Ocular involvement in pediatric patients with acute leukemia relapse: points of diagnosis and treatment
by: G. A. Radzhabova, et al.
Published: (2025-03-01) -
Myeloid/natural killer cell precursor acute leukaemia. Case report and literature review
by: V. R. Gorodetsky, et al.
Published: (2022-11-01) -
CD117 expression on blast cells in acute myeloid leukemia.
by: N. V. Goryainova, et al.
Published: (2015-09-01)